SCHEMBL6793790

SCHEMBL6793790

CC(CNC(=O)NCc1ccccc1)c1ccc(-c2ccsc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIA4 P48058 2/20 0.53
MAPT P10636 2/20 0.45
MEN1 O00255 1/20 0.45
ALDH1A1 P00352 1/20 0.45
KMT2A Q03164 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.44
LMNA P02545 1/20 0.43
OPRM1 P35372 6/20 0.43
OPRK1 P41145 4/20 0.43
OPRD1 P41143 3/20 0.43
ROCK2 O75116 1/20 0.43
ROCK1 Q13464 1/20 0.43
ADAM17 P78536 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.41
BACE1 P56817 1/20 0.41
CTSL P07711 1/20 0.41
CTSB P07858 1/20 0.41
CTSS P25774 1/20 0.41
CTSK P43235 1/20 0.41
EPHX1 P07099 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6784120 0.85 GRIA4 (0.54) GRIA4ROCK2ROCK1CTSLCTSB
SCHEMBL6788018 0.83 GRIA4 (0.60) GRIA4ALDH1A1OPRM1OPRK1OPRD1
SCHEMBL4584209 0.82 GRIA4 (0.63) GRIA4ALDH1A1CTSLCTSBCTSS
SCHEMBL6784440 0.82 GRIA4 (0.56) GRIA4MAPTALDH1A1KMT2ASMN1; SMN2
SCHEMBL6789267 0.82 GRIA4 (0.51) GRIA4MEN1KMT2ASMN1; SMN2LMNA
SCHEMBL7209225 0.82 GRIA4 (0.59) GRIA4ALDH1A1OPRM1OPRK1OPRD1
SCHEMBL6783719 0.80 GRIA4 (0.63) GRIA4ALDH1A1CTSLCTSBCTSS
SCHEMBL3278989 0.79 GRIA4 (0.53) GRIA4ALDH1A1SMN1; SMN2CTSLCTSB
SCHEMBL6790065 0.79 GRIA4 (0.61) GRIA4ALDH1A1CTSLCTSBCTSS
SCHEMBL6788393 0.78 GRIA4 (0.52) GRIA4ALDH1A1SMN1; SMN2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040097499-A1 Amide, carbamate, and urea derivatives ARNOLD MACKLIN BRIAN (US) 2004-05-20 US disclosed
US-6617351-B1 Amide, carbamate, and urea derivatives ELI LILLY AND COMPANY 2003-09-09 US disclosed
EP-0976744-A1 Amide, carbamate, and urea derivatives having glutamate receptor function potentiating activity ELI LILLY AND COMPANY (US) 2000-02-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040097499-A1 Amide, carbamate, and urea derivatives GRIN2A, GLUL, GRIK5 GRIA4 16/4885MAPT 406/4885MEN1 4531/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.